Prof. Dr. Özgür SÜRGİT

1. Reply to the Letter to the Editor: “Exploring the Multifaceted Nexus of Hypertrophic Cardiomyopathy and Clinical Outcomes”

BABUR GÜLER G., Güler A., Tanboğa İ. H., KARACAN M., Türkmen İ., Atmaca S., et al.

Anatolian Journal of Cardiology , cilt.30, sa.9, ss.624-625, 2026 (SCI-Expanded, Scopus, TRDizin)

2. Prevalence and characteristics of normal electrocardiograms in hypertrophic cardiomyopathy

Guler A., Gorgulu B. K., SÜRGİT Ö., Tanboga I. H., Turkmen I., Atmaca S., et al.

Journal of Electrocardiology , cilt.96, 2026 (SCI-Expanded, Scopus)

3. Phenotypic, Epidemiologic, and Imaging Features of Hypertrophic Cardiomyopathy: A Single-Center Experience

BABUR GÜLER G., Güler A., Tanboğa İ. H., KARACAN M., Türkmen İ., Atmaca S., et al.

Anatolian Journal of Cardiology , cilt.30, sa.5, ss.321-332, 2026 (SCI-Expanded, Scopus, TRDizin)

4. Silent Cerebral Embolism Following Left Ventricular Endocardial Ablation: The Silver Study

Akman C., YILDIZ M., SÜRGİT Ö., Aydın S., ÖNER E., GÜNER A., et al.

Journal of Cardiovascular Electrophysiology , cilt.36, sa.12, ss.3104-3115, 2025 (SCI-Expanded, Scopus)

5. Relationship between myocardial bridging and fatal ventricular arrhythmias in patients with hypertrophic cardiomyopathy: the HCM-MB study Zusammenhang zwischen myokardialem Bridging und letalen ventrikulären Arrhythmien bei Patienten mit hypertropher Kardiomyopathie: die HCM-MB-Studie

GÜNER A., Atmaca S., Balaban İ., Türkmen İ., Çeneli D., Türkvatan A., et al.

Herz , cilt.48, sa.5, ss.399-407, 2023 (SCI-Expanded, Scopus)

6. Low-dose thrombolytic therapy versus unfractionated heparin in patients with intermediate-high risk pulmonary embolism Orta yüksek riskli pulmoner emboli hastalarında düşük doz trombolitik tedaviye karşı fraksiyone olmayan heparin

SÜRGİT Ö., GÜNER A., Türkmen İ., KAHRAMAN S., Serbest N. G., Güner E. G., et al.

Ulusal Travma ve Acil Cerrahi Dergisi , cilt.29, sa.6, ss.677-684, 2023 (SCI-Expanded, Scopus, TRDizin)

7. High-density Mapping Catheter (Advisor™ HD Grid) Usage for Intra-atrial Reentrant Tachycardia Ablation in Children and Young Adult Patients with Congenital Heart Disease

Ergül Y., Kafalı H. C., ÖZTÜRK E., GÖKALP S., Şengül F. S., SÜRGİT Ö., et al.

Anatolian Journal of Cardiology , cilt.27, sa.6, ss.360-368, 2023 (SCI-Expanded, Scopus, TRDizin)

8. Acute effects of inhaled iloprost on intracardiac conduction in patients with pulmonary arterial hypertension Akute Wirkung von inhalativem Iloprost auf die intrakardiale Erregungsleitung bei Patienten mit pulmonalarterieller Hypertonie

YILDIZ M., KAHRAMAN S., SÜRGİT Ö., ZENCİRKIRAN AĞUŞ H., UYGUR B., DEMİR A. E., et al.

Herz , cilt.47, sa.2, ss.158-165, 2022 (SCI-Expanded, Scopus)

9. An unusual treatment of coronary injury following radiofrequency ablation in a 5-year-old child: Systemic steroid usage

YILDIZ M., KAHRAMAN S., Kafali H. C., SÜRGİT Ö., Ergul Y.

PACE - Pacing and Clinical Electrophysiology , cilt.43, sa.11, ss.1404-1407, 2020 (SCI-Expanded, Scopus)

10. The prognostic value of elevated matrix metalloproteinase-9 in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: A two-year prospective study Valor prognóstico da elevação das metaloproteinases de matriz 9 nos doentes submetidos a intervenção coronária percutânea primária por enfarte do miocárdio com supradesnivelamento do segmento ST: estudo prospetivo a dois anos

Somuncu M. U., PÜŞÜROĞLU H., Karakurt H., Bolat İ., Karakurt S. T., Demir A. R., et al.

Revista Portuguesa de Cardiologia , cilt.39, sa.5, ss.267-276, 2020 (SCI-Expanded, Scopus)

11. The relationship between plasma brain natriuretic peptide levels and left ventricular end-diastolic pressure and the extent of coronary artery involvement in chronic coronary artery disease Kronik koroner kalp hastaliǧinda serum beyin natriüretik peptid düzeyi ile sol ventrikül diyastol sonu basinci ve hastaliǧin derecesi arasindaki ilişki

Uslu N., Sayar N., Karabulut A., Nurkalem Z., ORHAN A. L., SÜRGİT Ö., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.34, sa.7, ss.413-418, 2006 (Scopus, TRDizin)

Prof. Dr. Özgür SÜRGİT

Yayınlar & Eserler

1. Reply to the Letter to the Editor: “Exploring the Multifaceted Nexus of Hypertrophic Cardiomyopathy and Clinical Outcomes”

2. Prevalence and characteristics of normal electrocardiograms in hypertrophic cardiomyopathy

3. Phenotypic, Epidemiologic, and Imaging Features of Hypertrophic Cardiomyopathy: A Single-Center Experience

4. Silent Cerebral Embolism Following Left Ventricular Endocardial Ablation: The Silver Study

5. Relationship between myocardial bridging and fatal ventricular arrhythmias in patients with hypertrophic cardiomyopathy: the HCM-MB study Zusammenhang zwischen myokardialem Bridging und letalen ventrikulären Arrhythmien bei Patienten mit hypertropher Kardiomyopathie: die HCM-MB-Studie

6. Low-dose thrombolytic therapy versus unfractionated heparin in patients with intermediate-high risk pulmonary embolism Orta yüksek riskli pulmoner emboli hastalarında düşük doz trombolitik tedaviye karşı fraksiyone olmayan heparin

7. High-density Mapping Catheter (Advisor™ HD Grid) Usage for Intra-atrial Reentrant Tachycardia Ablation in Children and Young Adult Patients with Congenital Heart Disease

8. Acute effects of inhaled iloprost on intracardiac conduction in patients with pulmonary arterial hypertension Akute Wirkung von inhalativem Iloprost auf die intrakardiale Erregungsleitung bei Patienten mit pulmonalarterieller Hypertonie

9. An unusual treatment of coronary injury following radiofrequency ablation in a 5-year-old child: Systemic steroid usage

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Proje

Tez Danışmanlığı

Açık Erişim